Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAOB | P27338 | 9/20 | 0.77 |
| ▸ | MAOA | P21397 | 8/20 | 0.77 |
| ▸ | PRKCI | P41743 | 1/20 | 0.77 |
| ▸ | HSD17B1 | P14061 | 2/20 | 0.58 |
| ▸ | PBRM1 | Q86U86 | 1/20 | 0.55 |
| ▸ | AKR1B1 | P15121 | 2/20 | 0.45 |
| ▸ | CYP26A1 | O43174 | 2/20 | 0.44 |
| ▸ | ESR1 | P03372 | 1/20 | 0.44 |
| ▸ | UGT1A1 | P22309 | 1/20 | 0.44 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.44 |
| ▸ | MIF | P14174 | 3/20 | 0.43 |
| ▸ | BAZ2B | Q9UIF8 | 1/20 | 0.43 |
| ▸ | GRM5 | P41594 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3825921 | 0.91 | MAOA (0.92) | MAOBMAOAPRKCIHSD17B1PBRM1 | |
| SCHEMBL228128 | 0.87 | MAOA (1.00) | MAOBMAOAPRKCIHSD17B1PBRM1 | |
| SCHEMBL5145478 | 0.83 | PBRM1 (0.78) | MAOBMAOAPRKCIHSD17B1PBRM1 | |
| SCHEMBL29983572 | 0.79 | PBRM1 (0.78) | MAOBMAOAPRKCIHSD17B1PBRM1 | |
| SCHEMBL385554 | 0.79 | PBRM1 (0.78) | MAOBMAOAPRKCIHSD17B1PBRM1 | |
| SCHEMBL389710 | 0.79 | MAOB (0.78) | MAOBMAOAPRKCIHSD17B1PBRM1 | |
| Hydrochloric Acid SCHEMBL6531236 | 0.76 | PBRM1 (0.72) | MAOBMAOAPRKCIHSD17B1PBRM1 | |
| SCHEMBL784291 | 0.76 | MAOB (0.59) | MAOBMAOAPRKCIHSD17B1PBRM1 | |
| SCHEMBL4090561 | 0.74 | HSD17B1 (1.00) | MAOBMAOAPRKCIHSD17B1PBRM1 | |
| SCHEMBL7245439 | 0.72 | MAOA (0.55) | MAOBMAOAPRKCIPBRM1ESR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2024025953-A2 | THERAPEUTIC USES OF UROLITHIN DERIVATIVES | VANDRIA SA (CH) | 2024-02-01 | — | — | WO | disclosed |